<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>DexCom (DXCM) Stock Is Up, What You Need To Know — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">DexCom (DXCM) Stock Is Up, What You Need To Know</h2>
    <div class="badge">2025-09-15T15:45:51+00:00</div>
    <ul>
      <li>After the initial pop the shares cooled down to $76.47, up 0.3% from previous close.</li>
<li>DexCom is down 2.6% since the beginning of the year, and at $76.47 per share, it is trading 15.7% below its 52-week high of $90.75 from February 2025.</li>
<li>Shares of medical device company DexCom (NASDAQ:DXCM) jumped 2.6% in the morning session after the company announced it would present new product features and positive clinical data at the European Association for the St</li>
<li>What Is The Market Telling Us DexCom’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year.</li>
<li>Bureau of Labor Statistics reported that the PPI, which measures wholesale prices, edged down 0.1% the previous month, contrary to analyst expectations for a 0.3% rise.</li>
<li>Investors who bought $1,000 worth of DexCom’s shares 5 years ago would now be looking at an investment worth $768.60.</li>
<li>The previous big move we wrote about was 5 days ago when the stock dropped 3.2% on the news that markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflatio</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=DexCom (DXCM) Stock Is Up, What You Need To Know\n• After the initial pop the shares cooled down to $76.47, up 0.3% from previous close.\n• DexCom is down 2.6% since the beginning of the year, and at $76.47 per share, it is trading 15.7% below its 52-week high of $90.75 from February 2025.\n• Shares of medical device company DexCom (NASDAQ:DXCM) jumped 2.6% in the morning session after the company announced it would present new product features and positive clinical data at the European Association for the St\n• What Is The Market Telling Us DexCom’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year.\n• Bureau of Labor Statistics reported that the PPI, which measures wholesale prices, edged down 0.1% the previous month, contrary to analyst expectations for a 0.3% rise.\n• Investors who bought $1,000 worth of DexCom’s shares 5 years ago would now be looking at an investment worth $768.60.\n• The previous big move we wrote about was 5 days ago when the stock dropped 3.2% on the news that markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflatio" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/dexcom-dxcm-stock-know-154551918.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>